Browsing by Author Luk, F

Showing results 1 to 20 of 23  next >
Issue DateTitleAuthor(s)
23-May-2016Multiple myeloma and persistence of drug resistance in the age of novel drugsKrishnan, SR; Jaiswal, R; Brown, RD; Luk, F; Bebawy, M
1-Sep-2015Abstract B45: Multiple myeloma: A novel tailor-made therapeutic management.Krishnan, SR; Bebawy, M; Luk, F; Brown, RD; Kwan, YL
1-Aug-2015Microparticles as novel prognostic markers in multiple myelomaRajeev Krishnan, S; Bebawy, M; Brown, RD; Luk, F; Kwan, Y
Jun-2015Fabrication of Curcumin Micellar Nanoparticles with Enhanced Anti-Cancer Activity.Lee, W-H; Bebawy, M; Loo, C-Y; Luk, F; Mason, RS; Rohanizadeh, R
4-Apr-2015Microparticles in Cancer: A Review of Recent Developments and the Potential for Clinical Application.Gong, J; Jaiswal, R; Dalla, P; Luk, F; Bebawy, M
Apr-2015Microparticles in cancer: A review of recent developments and the potential for clinical applicationGong, J; Jaiswal, R; Dalla, P; Luk, F; Bebawy, M
Jan-2015Targeting microparticle biogenesis: a novel approach to the circumvention of cancer multidrug resistance.Roseblade, A; Luk, F; Ung, A; Bebawy, M
2015A novel personalized therapeutic management in multiple myelomaKrishnan, RS; Luk, F; Brown, R-D; Kwan, Y-L; Bebawy, M
2015Microparticles derived from drug-resistant cells regulate miR-503 and PYK2 to promote migration and invasion in breast cancerGong, J; Luk, F; Jaiswal, R; Bebawy, M
2015Functional translation of total RNA packaged in microparticles shed from multidrug resistant cancer cellsBebawy, M; Lu, J-F; Pokharel, D; Luk, F
15-Aug-2014Microparticles Mediate the Intercellular Regulation of microRNA-503 and Proline-Rich Tyrosine Kinase 2 to Alter the Migration and Invasion Capacity of Breast Cancer Cells.Gong, J; Luk, F; Jaiswal, R; Bebawy, M
Aug-2014SYNTHESIS OF CURCUMIN NANOPARTICLES FOR LUNG CANCER THERAPYLee, W-H; Ong, H-X; Loo, C-Y; Traini, D; Young, PM; Luk, F; Bebawy, M; Rohanizadeh, R
Apr-2014Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?Callaghan, R; Luk, F; Bebawy, M
Jan-2014Proteome analysis of multidrug-resistant, breast cancer-derived microparticles.Pokharel, D; Padula, MP; Lu, JF; Tacchi, JL; Luk, F; Djordjevic, SP; Bebawy, M
Jan-2013Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistanceGong, J; Luk, F; Jaiswal, R; George, AM; Grau, G; Bebawy, M
Jan-2013Cell-Derived Microparticles: New Targets in the Therapeutic management of diseaseRoseblade, AP; Luk, F; Rawling, T; Ung, AT; Grau, G; Bebawy, M
Jan-2013Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistanceGong, J; Luk, F; Jaiswal, R; George, AM; Grau, G; Bebawy, M
Jan-2013Curcumin and its Derivatives: Their Application in Neuropharmacology and Neuroscience in the 21st CenturyLee, W; Loo, CY; Bebawy, M; Luk, F; Mason, R; Rohanizadeh, R
Jan-2013Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways.Lu, JF; Luk, F; Gong, J; Jaiswal, R; Grau, G; Bebawy, M
Jan-2013Breast Cancer-Derived Microparticles Display Tissue Selectivity in the Transfer of Resistance Proteins to CellsJiswal, R; Luk, F; Dalla, P; Grau, G; Bebawy, M